News

Video

Revolutionizing Frontline Therapy for Endometrial Cancer: Checkpoint Inhibitors and MMR Status

Explore the groundbreaking shift in frontline treatment for endometrial cancer, driven by recent data from trials like RUBY and GY018, highlighting the significant impact of checkpoint inhibitors in patients with mismatch repair deficiency.

Video Player is loading.
Current Time 0:00
Duration 8:36
Loaded: 0%
Stream Type LIVE
Remaining Time 8:36
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected